THE ADVERSE-EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY

被引：0
|
作者：
WONG, KC [1 ]
LI, PKT [1 ]
LUI, SF [1 ]
NICHOLLS, MG [1 ]
LAI, KN [1 ]
机构：
[1] CHINESE UNIV HONG KONG, DEPT MED, SHA TIN, HONG KONG
来源：
ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS | 1990年 / 9卷 / 04期
关键词：
UREMIA; ANEMIA; DIALYSIS; ERYTHROPOIETIN; ADVERSE EFFECTS;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：183 / 206
页数：24
相关论文
共 50 条
  • [1] PRACTICAL APPROACH TO INITIATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY AND PREVENTION AND MANAGEMENT OF ADVERSE-EFFECTS
    ABRAHAM, PA
    AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 : 7 - 14
  • [2] THERAPY WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    STONE, RM
    BERNSTEIN, SH
    DEMETRI, G
    FACKLAM, DP
    ARTHUR, K
    ANDERSEN, J
    ASTER, JC
    KUFE, D
    LEUKEMIA RESEARCH, 1994, 18 (10) : 769 - 776
  • [3] THE USES OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    PATTERSON, KG
    SAUDI MEDICAL JOURNAL, 1994, 15 (01) : 1 - 13
  • [4] IMPROVED SEXUAL FUNCTION DURING RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY
    BOMMER, J
    KUGEL, M
    SCHWOBEL, B
    RITZ, E
    BARTH, HP
    SEELIG, R
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (03) : 204 - 207
  • [5] INTRAPERITONEAL ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    FRENKEN, LAM
    STRUIJK, DG
    COPPENS, PJW
    TIGGELER, RGWL
    KREDIET, RT
    KOENE, RAP
    PERITONEAL DIALYSIS INTERNATIONAL, 1992, 12 (04): : 378 - 383
  • [6] RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN CHILDREN MAINTAINED BY HEMODIALYSIS
    RIGDEN, SPA
    MONTINI, G
    MORRIS, M
    CLARK, KGA
    HAYCOCK, GB
    CHANTLER, C
    HILL, RC
    PEDIATRIC NEPHROLOGY, 1990, 4 (06) : 618 - 622
  • [7] EFFECTIVENESS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN MYELODYSPLASTIC SYNDROMES
    ADAMSON, JW
    SCHUSTER, M
    ALLEN, S
    HALEY, NR
    ACTA HAEMATOLOGICA, 1992, 87 : 20 - 24
  • [8] ERYTHROPOIETIN RESPONSE TO ANEMIA IS NOT ALTERED BY SURGERY OR RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY
    GOODNOUGH, LT
    PRICE, TH
    PARVIN, CA
    FRIEDMAN, KD
    VOGLER, WR
    KHAN, N
    SACHER, R
    JOHNSTON, M
    WISSEL, M
    CIAVARELLA, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) : 695 - 699
  • [9] EFFICACY OF ORAL IRON THERAPY IN PATIENTS RECEIVING RECOMBINANT-HUMAN-ERYTHROPOIETIN
    WINGARD, RL
    PARKER, RA
    ISMAIL, N
    HAKIM, RM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) : 433 - 439
  • [10] ADVERSE EVENTS OF SUBCUTANEOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY - RESULTS OF A CONTROLLED MULTICENTER EUROPEAN STUDY
    KLINKMANN, H
    WIECZOREK, L
    SCIGALLA, P
    ARTIFICIAL ORGANS, 1993, 17 (04) : 219 - 225
12345